Andreessen Horowitz (a16z)General Partner, Bio + Health
2019 — Present
Leads investments in companies transforming healthcare access, payment, infrastructure, and delivery.
Julie Yoo invests in healthcare technology as a general partner at Andreessen Horowitz.
Julie Yoo invests in healthcare technology as a general partner at Andreessen Horowitz.
2019 — Present
Leads investments in companies transforming healthcare access, payment, infrastructure, and delivery.
2010 — 2018
Co-founded the care-access company and led product as its platform scaled to 20 million patients and more than 225,000 healthcare providers.
2009 — 2010
Led product at the molecular-diagnostics benefit-management company before its acquisition by CVS Health.
2007 — 2009
Built whole-genome analysis and interpretation products.
2001 — 2006
Worked on enterprise search and business-intelligence software before Endeca's acquisition by Oracle.
A top-of-mind question for founders and investors these days is how to build a business that gets stronger as frontier models improve, without becoming vulnerable to them.
The first iteration of digital health was basically a skeuomorphic recreation of a traditional doctor's visit on a computer screen.

There's generational replacement cycle happening in the commercial health plan market, and a previously impenetrable category is now addressable for startups.
